Subscribe to our Newsletter!
Cerca
Solutions
Innovation
Knowledge
People
Contact Us
EN
中文 日本
Solutions
Innovation
Knowledge
People

By Approach

Clinical Labs Business Alliances Industrial World

By Trending Field

Respiratory Infections Antibiotic Resistances Clinical Automation Molecular Biology All Applications Fields
All Products

Copan Technologies

WISE approach FLOQ® Technology LBM® technology Digital Microbiology

Programs

Quality First Science and R&D Futura Invent

Sharing

Blog & News Events and Fairs

Resources

e-labelling Quality Certificates Certificates of Analysis Patents Trademarks

More Than Just a Brand

About Working at Copan

Get Involved

Open Positions Contacts
Solutions

By Approach

Clinical Labs Business Alliances Industrial World

By Trending Field

Respiratory Infections Antibiotic Resistances Clinical Automation Molecular Biology All Applications Fields
All Products
Innovation

Copan Technologies

WISE approach FLOQ® Technology LBM® technology Digital Microbiology

Programs

Quality First Science and R&D Futura Invent
Knowledge

Sharing

Blog & News Events and Fairs

Resources

e-labelling Quality Certificates Certificates of Analysis Patents Trademarks
People

More Than Just a Brand

About Working at Copan

Get Involved

Open Positions Contacts
Contact Us
EN
中文 日本

Search results for:

Copan Group
Pages (5)
Scientific Studies (11)
Events & Fairs (6)
News (10)

Application

SELF UriSponge™
SELF LolliSponge™
HPV
screening

Self-Collection

Simplifying collection devices and ensuring a prolonged sample transport could promote self-collection expansion in many new medical fields.

Self-Collection
Copan Group

Product

FLOQSwabs®
Self Collection
STI and HPV
HPV

Self Vaginal FLOQSwabs®

Safe, comfortable, and easy to use, Self Vaginal FLOQSwabs® is the comfortable device supporting women taking part in HPV and STI screening campaigns.

Self FLOQSwabs® Vaginal
Copan Group

Application

eSwab®
eNat®
MSwab®
UTM®

STIs and Cervical Cancer

Although most STIs have no or only mild symptoms, the 1 million STIs acquired every day profoundly impact global health worldwide.

STIs and Cervical Cancer
Copan Group

Application

SRK®
Transystem™
HAI
Hospital Acquired Infections

Hospital Acquired Infections

The rise of Multi Drug-Resistant Organisms has become a global health and economic concern, and tools to combat them are urgently needed.

Hospital Acquired Infections
Copan Group

Product

FLOQSwabs®
UTM®
UniVerse™
Covid-19

UTM® PodSwab™

PodSwab™ is the 6 ml UTM® tube paired with five nasal flocked swabs that allows for pooling up to five different individual samples in one single tube.

UTM® PodSwab™
Copan Group

Scientific Study

ECCMID
2019
eSwab®
WASPLab®
time saving
image analysis vs visual examination

Can image analysis automatically screen for Streptococcus agalactiae in specimens collected from pregnant women?

J. Steenbergen
Source

Scientific Study

Front Cell Infect Microbiol
2020
screening
total lab automation
TAT Urine
MRSA-ESBI-VRE

Impact of Total Laboratory Automation on Turnaround Times for Urine Cultures and Screening Specimens for MRSA, ESBL, and VRE Carriage: Retrospective Comparison with Manual Workflow

Abdessalam Cherkaoui, Gesuele Renzi, Romain Martischang, Stephan Harbarth, Nicolas Vuilleumier and Jacques Schrenzel
Source

Scientific study

Epidemiology & Infection
2021
SELF LolliSponge™
Self Collection
Saliva
Covid-19

Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience

Emerenziana Ottaviano et al.
Source

Scientific Study

Frontiers
2022
UTM®
SELF LolliSponge™
Self Collection
Virology

Feasibility and acceptability of saliva-based testing for the screening of SARS-CoV-2 infection in prison

C. Parodi, E. Ottaviano, N. Cocco, S. Ancona, S. Bianchi, V. Massa, R. Bartolotti, B. Pezzoni, R. Giuliani, E. Borghi, R. Ranieri
Source

Scientific study

Diagnostics
2022
SELF FLOQSwabs®
Vaginal
HPV
Human Papillomavirus

Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study

Marianna Martinelli et al.
Source

Scientific study

Eur J Clin Microbiol Infect Dis .
2020
Nasal
mrsa
eswab
Molecular biology

Performance of the Hologic Panther Fusion® MRSA Assay for the nasal screening of methicillin-sensitive and methicillin-resistant Staphylococcus aureus carriage

E. Maurin et al

Source

Scientific study

Jama
2023
HPV
Human Papillomavirus
screening
FLOQSwabs

Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial

Rachel L. Winer et al.

Source

Scientific study

BMJ - Sexually Transmitted infections
2024
FLOQ®
HPV
screening
FLOQSwabs

Performance evaluation of a self-administered point-of-care test for anal HPV screening in PrEP users: data from a community-based PrEP service

Lorenzo Biasioli et al.

Source

Scientific study

Asian Pacific Journal of Cancer Prevention
2024
HPV
screening
Human Papilloma Virus
Self-Collection

Acceptance of Self-Sampling and Knowledge about Human Papillomavirus among Women in Mongolia

Tsetsegsaikhan Batmunkh et al.

Source

Scientific study

Journal of Molecular Diagnostics
2024
Vaginal
HPV
Human Papillomavirus
screening

Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs

Michele Qi et al.

Source

Scientific study

eClinical Medicine
2024
HPV
Human Papillomavirus
screening
FLOQSwabs

Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)

Anita W. W. Lim et al.

Source

Fair

April 10-12, 2022
Congress Center Düsseldorf, Germany
Booth E1
HPV
Sample Preparation
screening
FLOQSwabs

EUROGIN 2022 – International multidisciplinary HPV congress

We urgently need to recover from the losses in cervical cancer screening and treatment and HPV vaccination rates that we witnessed during the COVID-19 pandemic; EUROGIN is the opportunity to meet in person to share ideas on the ambitious goal of eliminating cervical cancer. At the booth, you’ll have the chance to discover our solutions for HPV screening and our approach to self-collection as a method to increase testing rates in women.

Discover

Fair

27-28 October
Verona, Italy
HPV
screening
Cervical Cancer
prevention

GISCi – Convegno Gruppo Italiano Screening del Cervicocarcinoma

Il Gruppo Italiano Screening del Cervicocarcinoma è una associazione senza scopi di lucro che promuove la diffusione e miglioramento della qualità nell’attività di screening organizzato del carcinoma della cervice uterina. Il Convegno nazionale sarà un’occasione di confronto per quanti coinvolti nei programmi di screening organizzato nel verificare i risultati raggiunti, i programmi di recupero dopo il rallentamento dell’attività legato alla pandemia COVID, il grado di implementazione nell’attuazione del Programma Nazionale di Prevenzione per quanto attiene, nello specifico, l’attività dell’Associazione.

Discover

Fair

16-18 November, 2022
Sofitel hotel, Melborune, Australia
Booth 4
SELF FLOQSwabs®
Self Collection
HPV
screening

Preventing Cervical Cancer 2022 Conference

The PCC2022 Conference will be a hybrid face-to-face and virtual event hosted by the Australian Centre for the Prevention of Cervical Cancer and the NHMRC-funded Centre of Research Excellence in Cervical Cancer Control (C4).

The theme of the conference is innovation and equity in the elimination of cervical cancer. An exciting panel of speakers at the vanguard of elimination efforts will share their experiences and knowledge across the cervical cancer prevention spectrum, including awareness, vaccination, screening, and treatment of pre-cancers. In a few words, PCC222 is the ideal setting for our vaginal self-collection products.

Discover

Fair

October 26-27, 2023
University of Milan, Italy
HPV
screening
Cervical Cancer
prevention

GISCi – Convegno Gruppo Italiano Screening del Cervicocarcinoma

Il Gruppo Italiano Screening del Cervicocarcinoma (GISCi ) è una associazione senza scopi di lucro che promuove la diffusione e miglioramento della qualità dell’ attività di screening organizzato del “carcinoma della cervice uterina”. Obiettivi principali del GISCi sono: promuovere i contatti tra i programmi di screening esistenti in Italia; favorire il confronto multidisciplinare tra i vari professionisti ed operatori coinvolti nel percorso di screening; promuovere la qualità dei programmi nonché sostenere e stimolare l’innovazione e la ricerca nel settore. Punto saliente per la valutazione del raggiungimento di tali obiettivi è il Convegno Nazionale annuale che quest’anno si terrà a Milano dal 26 al 27 Ottobre.
Sarà un’occasione di confronto per quanti coinvolti nei programmi di screening organizzato nel verificare i risultati raggiunti, i programmi di recupero dopo il rallentamento dell’attività legato alla pandemia COVID, il grado di implementazione nell’attuazione del Programma Nazionale di Prevenzione per quanto attiene, nello specifico l’attività della Associazione.

Discover

Fair

July 17-19, 2025
Tokyo, Japan
screening
Cervical Cancer
prevention
HPV

67th Annual Meeting of the Asian Society of Gynecologic Oncology

This year’s topic of the ASGO meeting is “New perspectives in gynecologic oncology: care beyond cure”. Attend our symposium “Revolutionizing Cervical Screening: Self-Collection as a Game-Changer for Engagement and Participation” on July 18th or come along to our booth, where we’ll be showing our state-of-the-art collection devices!

Discover

Fair

July 26-30, 2025
Montreal, Canada
A03
screening
STI
Cervical Cancer
prevention

STI&HIV 2025 World Congress

The theme of the 2025 Congress is “Sexual Health for All“. This international congress will gather an inclusive group of researchers, clinicians, laboratorians, public health practitioners, community members, and advocates from around the world to share ground-breaking clinical and basic science, innovative public health interventions, and evidence-based best practices in STI/HIV.
Visit our booth and take the opportunity to network with your peers and respected leaders in the field at the Product Theatre, where we will hold a speech on self collection on July 28th.
We are proud to collaborate on shaping the future of STI and HIV in a sexual health vision.

Discover

News

July 30, 2021
Covid-19
screening
Product launch
pooling

Launch of PodSwab™ – UTM® for pooling

Many scientific studies have demonstrated pooled testing to be an efficient methodology for screening in the case of low-incidence phases of COVID-19. We are now ready to present PodSwab™ – UTM® for pooling: another Copan solution to streamline laboratory workflow in COVID-19 screening.

Read more
Copan Group

Microbiology time

February 3, 2022
Saliva
Swab
Automation
Covid-19

Microbiology Time – February 2022

It’s February, and it’s Microbiology Time! This month we selected an exciting paper on MDRO outbreaks during the Covid-19 pandemic and an interesting study evaluating the performance of different swab types and collection systems to recover CMV DNA from vaginal fluids and saliva. The third study selected is an exhaustive review of the advantages of full lab automation.

Read more
Copan Group

Microbiology time

June 10, 2022
FLOQSwabs®
HPV
Outbreak
screening

Microbiology Time – June 2022

June’s microbiology time is finally online! We selected three interesting studies for this month’s issue: a paper published on BMC evaluating HPV testing using self-collected samples and two studies on two very different outbreaks, the first of measles in Italian non-vaccinated individuals and the second investigating an outbreak of CPE in a COVID-19 intensive care unit.

Read more
Copan Group

Microbiology Time

September 12, 2022
HAI
Saliva
screening
surface

Microbiology Time – September 2022

Happy September, Microbiology Time readers! We spent August selecting the best papers featuring our products. This month the topics are heterogeneous and meet all tastes: a saliva-based SARS-CoV-2 screening, olfactory swabbing for alpha-synuclein detection in Parkinson’s patients, and a study on surface contamination by monkeypox.

Read more
Copan Group

Microbiology Time

February 8, 2023
Buccal
Vaginal
HPV
Human Papillomavirus

Microbiology Time – February 2023

It’s the second month of 2023, and it’s the second microbiology time of the year! In this edition, we selected studies covering self-collected vaginal samples for molecular assays, SARS-Cov-2 detection from rectal and nasal swabs, and buccal swabbing for BRCA testing. Enjoy your reading!

Read more
Copan Group

Microbiology Time

October 12, 2023
Vaginal
HPV
Human Papillomavirus
Tuberculosis

Microbiology Time – October 2023

Let’s dig together into three thrilling papers on tongue swabs and tuberculosis, self-collection for cervical screening in Italian women, and a study on the correlation between Covid-related olfactory deficit and zinc homeostasis.

Read more
Copan Group

Microbiology Time

February 7, 2024
Saliva
HPV
Human Papillomavirus
eswab

Microbiology Time – February 2024

In the second Microbiology Time of 2024, we selected a paper proposing salivary micro-RNA as a liquid biopsy marker in oral cancer, a clinical trial evaluating different methods of offering HPV self-sampling kits, and a study investigating the benefits of probiotics in improving microbiota composition in post-menopausal women.

Read more
Copan Group

Microbiology Time

May 16, 2024
HPV
screening
FLOQSwabs
UTM

Microbiology Time – May 2024

In the May edition of our Microbiology Time, we have selected three papers that showcase the diverse applications of our products, from HPV self-collection to a validation of an animal model and a zoonosis case study.

Read more
Copan Group

Microbiology Time

July 3, 2024
Vaginal
HPV
Human Papillomavirus
DNA

Microbiology Time – July 2024

We welcome the long-awaited summer with three great papers: the first analyzes surface characteristics’ effect on human DNA’s recovery for forensic purposes, while the second and third evaluate the impact of different variables on the accuracy and usability of self-collected samples for HPV detection.

Read More
Copan Group

Microbiology Time

August 1, 2024
Genetics
HPV
Human Papillomavirus
screening

Microbiology Time – August 2024

To select this month’s studies, we’ve traveled to three continents with an epidemiology study on pneumococcus in Botswana, an update on the British HPV screening program YouScreen, and an E. coli sequencing project in Pakistan.

Read more
Copan Group
Any content
Product Code

I'm looking for...

Any content
Product code
Any Content
Product Code

Popular search

Self FLOQ Rapid AST

Solutions

Clinical lab Clinical Business Industrial world
Close Search

We love to talk
to people

Write us to satisfy your curiosity, get information or start a great collaboration!

Contact us for more info

Are you looking
for something?

Use our search tool and be surprised by how easy it is to get right to the point.

Search

About

Company Contacts Press Releases Work with us Sustainability Report HSE Policy

Solutions

Clinical Labs Business Alliances Industrial World All products

Innovation

WISE approach FLOQ® Technology LBM® technology Digital Microbiology Quality First Science & R&D Futura Invent

Knowledge

Blog & News Events and Fairs

Resources

e-labelling Quality Certificates Certificates of Analysis Patents Trademarks

Ethics & Compliance

PSCL Model 231 Conditions of Use Privacy Transparency Report Whistleblowing
EN
中文 日本
COPAN ITALIA spa Via F. Perotti 10, 25125 Brescia - Italy
C.F. e numero iscrizione Registro delle Imprese di Brescia: 01740560170. -P. IVA - ID VAT nr. IT 01740560170
Capitale sociale € 6.000.000 I.V.
copan group
copan group
copan group

Contact

Thank you!Your submission
has been received!
Oops! Something went wrong while submitting the form.

Newsletter

Thank you!Your submission
has been received!
Oops! Something went wrong while submitting the form.